Korea blueprints $14.3B biotech investment plan

Korea's government has unveiled plans to invest $14.3 billion into the country's biotech industry to support research and commercialization efforts. Korea's goal is to push the biotech industry to become a $60 billion market by 2016. The government wants to integrate biotech work with advances in genomics, information technology and nanotechnology. There are also plans to provide clear ethical oversight to make sure there's no repeat of the recent humiliating scandal over faked research by Hwang Woo-suk.

- here's the report from The Korea Times

Suggested Articles

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.